Paid Clinical Trials Vermont
Discover 208 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor:
NRG Oncology
Location:
Code:
NCT05879926
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Ovarian Function Suppression + Aromatase Inhibitor
Adjuvant Chemotherapy + Ovarian Function Suppression
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
Sponsor:
AstraZeneca
Location:
Code:
NCT06268873
Conditions
Chronic Kidney Disease and Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Baxdrostat/dapagliflozin
Dapagliflozin in combination with placebo
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Sponsor:
Dennis M. McNamara, MD, MS
Location:
Code:
NCT05180773
Conditions
Peripartum Cardiomyopathy, Postpartum
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bromocriptine
Placebo
Guideline Directed Medical Therapy for Heart Failure (GDMT)
Rivaroxaban
Second Placebo
His-Bundle Corrective Pacing in Heart Failure
Sponsor:
University of Rochester
Location:
Code:
NCT05265520
Conditions
Right Bundle-Branch Block
Heart Failure
His-bundle Pacing
Cardiac Resynchronization Therapy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
His-CRT implantation
BIV-CRT implantation
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT05636176
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ziltivekimab
Placebo
Efficacy of a Clinic-based, Multi- Disciplinary, Pediatric Weight Management Program
Sponsor:
University of Vermont
Location:
Code:
NCT01857791
Conditions
Body Weight Changes
Eligibility Criteria
Sex: All
Age: 12 - 18
Healthy Volunteers: Not accepted
Interventions
multidisciplinary, behavior modification
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Sponsor:
NRG Oncology
Location:
Code:
NCT05095376
Conditions
Glioblastoma
Gliosarcoma
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Lomustine
Photon Beam Radiation Therapy
Quality-of-Life Assessment
Questionnaire Administration
Temozolomide
Sinus Disease in Young Children With Cystic Fibrosis
Sponsor:
UCLA
Location:
Code:
NCT06191640
Conditions
Cystic Fibrosis in Children
Cystic Fibrosis
Chronic Rhinosinusitis (Diagnosis)
Olfactory Disorder
Olfactory Impairment
Eligibility Criteria
Sex: All
Age: 2 - 8
Healthy Volunteers: Not accepted
Interventions
Ivacaftor or elexacaftor/tezacaftor/ivacaftor
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
Sponsor:
Pliant Therapeutics, Inc.
Location:
Code:
NCT06097260
Conditions
Idiopathic Pulmonary Fibrosis
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
PLN-74809
Placebo
Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes
Sponsor:
University of Vermont
Location:
Code:
NCT06692894
Conditions
Myelodysplastic Syndromes, Adult
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Observational